Correlation Between Entheon Biomedical and Supercom

Can any of the company-specific risk be diversified away by investing in both Entheon Biomedical and Supercom at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entheon Biomedical and Supercom into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Entheon Biomedical Corp and Supercom, you can compare the effects of market volatilities on Entheon Biomedical and Supercom and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entheon Biomedical with a short position of Supercom. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entheon Biomedical and Supercom.

Diversification Opportunities for Entheon Biomedical and Supercom

-0.35

Correlation Coefficient

Entheon Biomedical  Supercom

Very good diversification

The 3 months correlation between Entheon and Supercom is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Entheon Biomedical Corp and Supercom in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Supercom and Entheon Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entheon Biomedical Corp are associated (or correlated) with Supercom. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Supercom has no effect on the direction of Entheon Biomedical i.e., Entheon Biomedical and Supercom go up and down completely randomly.

Pair Corralation between Entheon Biomedical and Supercom

Assuming the 90 days horizon Entheon Biomedical Corp is expected to generate 7.57 times more return on investment than Supercom. However, Entheon Biomedical is 7.57 times more volatile than Supercom. It trades about 0.13 of its potential returns per unit of risk. Supercom is currently generating about 0.0 per unit of risk. If you would invest  10.00  in Entheon Biomedical Corp on September 18, 2024 and sell it today you would earn a total of  2.00  from holding Entheon Biomedical Corp or generate 20.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Entheon Biomedical Corp  vs.  Supercom

Entheon Biomedical Corp

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Entheon Biomedical Corp are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental drivers, Entheon Biomedical reported solid returns over the last few months and may actually be approaching a breakup point.

Supercom

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Supercom has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental indicators, Supercom is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Entheon Biomedical and Supercom

The main advantage of trading using opposite Entheon Biomedical and Supercom positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entheon Biomedical position performs unexpectedly, Supercom can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Supercom will offset losses from the drop in Supercom's long position.

The idea behind Entheon Biomedical Corp and Supercom pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.